• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性乳腺癌及其淋巴结转移灶的倍性和S期细胞分数(SPF)。

Ploidy and S-phase fractions (SPF) of primary breast cancers and their nodal metastases.

作者信息

Hupperets P S, Schutte B, van Assche C, Schouten L J, Jager J, de Jong J, Blijham G H

机构信息

Department of Internal Medicine, Academic Hospital Maastricht, The Netherlands.

出版信息

Breast Cancer Res Treat. 1994;32(2):197-202. doi: 10.1007/BF00665770.

DOI:10.1007/BF00665770
PMID:7865849
Abstract

Ninety-one cases of primary breast cancers and their nodal metastases were examined with DNA flow cytometry. No differences were found between the stemline distributions in the primary tumors and nodal metastases. At both sites stemlines clustered around a DNA index of 1.0 (33-40% of cases) and 1.8. The mean S-phase fractions were 7.9 in primary tumors versus 5.6% in nodal metastases (p = 0.02); this difference was also observed if the analysis was restricted to cases with DNA aneuploidy at both sites (10.2 versus 7.6%, p = 0.04). Our results indicate that axillary nodal ploidy and proliferation reflect primary tumor characteristics rather than displaying changes associated with selection during the lymphatic metastatic process. Lymph nodes may have a suppressive effect on the proliferation of tumor cells.

摘要

对91例原发性乳腺癌及其淋巴结转移灶进行了DNA流式细胞术检测。原发性肿瘤和淋巴结转移灶的干系分布无差异。在两个部位,干系均聚集在DNA指数1.0(33 - 40%的病例)和1.8左右。原发性肿瘤的平均S期分数为7.9%,而淋巴结转移灶为5.6%(p = 0.02);如果分析仅限于两个部位均为DNA非整倍体的病例,也观察到了这种差异(10.2%对7.6%,p = 0.04)。我们的结果表明,腋窝淋巴结的倍性和增殖反映了原发性肿瘤的特征,而不是显示与淋巴转移过程中的选择相关的变化。淋巴结可能对肿瘤细胞的增殖有抑制作用。

相似文献

1
Ploidy and S-phase fractions (SPF) of primary breast cancers and their nodal metastases.原发性乳腺癌及其淋巴结转移灶的倍性和S期细胞分数(SPF)。
Breast Cancer Res Treat. 1994;32(2):197-202. doi: 10.1007/BF00665770.
2
Flow cytometric analysis of primary tumors and their corresponding metastatic nodes in breast cancer.
Breast Cancer Res Treat. 2000 Sep;63(1):81-7. doi: 10.1023/a:1006470614782.
3
Predictive value of flow cytometry for metastatic potential in breast cancer.
Am Surg. 1999 May;65(5):434-8.
4
Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.我们能否确定具有最小腋窝淋巴结受累风险的小浸润性(T1a,b)乳腺癌群体?一项组织病理学和 DNA 流式细胞术研究。
Pathol Res Pract. 2011 Jul 15;207(7):438-42. doi: 10.1016/j.prp.2011.04.005. Epub 2011 Jun 20.
5
High levels of DNA index heterogeneity in advanced breast carcinomas. Evidence for DNA ploidy differences between lymphatic and hematogenous metastases.晚期乳腺癌中DNA指数高度异质性。淋巴转移和血行转移之间DNA倍性差异的证据。
Cancer. 1993 Jan 15;71(2):382-91. doi: 10.1002/1097-0142(19930115)71:2<382::aid-cncr2820710219>3.0.co;2-9.
6
S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.乳腺癌患者长期预后中的S期分数与细胞核大小
Cancer. 1994 Oct 15;74(8):2287-99. doi: 10.1002/1097-0142(19941015)74:8<2287::aid-cncr2820740813>3.0.co;2-y.
7
DNA index and cell cycle analysis of primary breast cancer and synchronous axillary lymph node metastases.原发性乳腺癌及同步腋窝淋巴结转移灶的DNA指数与细胞周期分析
Breast Cancer Res Treat. 1989 Jan;13(1):17-22. doi: 10.1007/BF01806546.
8
Prediction of axillary lymph node metastases in a screened breast cancer population. South-East Sweden Breast Cancer Group.筛查的乳腺癌人群中腋窝淋巴结转移的预测。瑞典东南部乳腺癌研究组。
Acta Oncol. 1994;33(6):603-8. doi: 10.3109/02841869409121769.
9
The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
Pathol Res Pract. 1989 Nov;185(5):694-7. doi: 10.1016/S0344-0338(89)80219-5.
10
Evaluation and reinforcement of the correlation of S-phase fraction with nodal metastases, tumor grade and tumor size in breast carcinoma patients in Pakistan.巴基斯坦乳腺癌患者中S期分数与淋巴结转移、肿瘤分级及肿瘤大小相关性的评估与强化
Pathol Res Pract. 2001;197(8):531-6. doi: 10.1078/0344-0338-00123.

本文引用的文献

1
Flow cytometry of breast carcinoma. III. Possible altered kinetics in axillary lymph node metastases.乳腺癌的流式细胞术。III. 腋窝淋巴结转移中可能改变的动力学
Anal Quant Cytol. 1982 Dec;4(4):275-8.
2
Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.细胞DNA含量对II期乳腺癌患者无病生存期的影响。
Cancer Res. 1984 Nov;44(11):5395-8.
3
A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis.一种用于制备细胞核以进行流式细胞术DNA分析的去污剂-胰蛋白酶法。
Cytometry. 1983 Mar;3(5):323-7. doi: 10.1002/cyto.990030503.
4
Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
Cancer Res. 1987 Sep 1;47(17):4729-35.
5
DNA ploidy and survival in breast cancer patients.乳腺癌患者的DNA倍体与生存情况
Cytometry. 1987 Mar;8(2):225-34. doi: 10.1002/cyto.990080217.
6
Comparison of phenotypic and genotypic features in human primary large bowel carcinomas and lymph node metastases.人类原发性大肠癌及淋巴结转移灶的表型与基因型特征比较。
Cancer Res. 1987 Aug 15;47(16):4342-4.
7
DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.1331例冷冻乳腺癌标本的DNA流式细胞术及预后因素
Cancer. 1988 Feb 1;61(3):420-7. doi: 10.1002/1097-0142(19880201)61:3<420::aid-cncr2820610303>3.0.co;2-0.
8
Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.通过结合DNA指数和S期分数提高DNA流式细胞术在乳腺癌中的预后价值。一种提议的乳腺癌DNA直方图分类。
Cancer. 1988 Nov 15;62(10):2183-90. doi: 10.1002/1097-0142(19881115)62:10<2183::aid-cncr2820621019>3.0.co;2-b.
9
The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer.流式细胞术与原发性乳腺癌淋巴结阴性女性的临床及生物学特征之间的关系。
Cancer. 1989 Nov 1;64(9):1894-900. doi: 10.1002/1097-0142(19891101)64:9<1894::aid-cncr2820640923>3.0.co;2-k.
10
DNA index and cell cycle analysis of primary breast cancer and synchronous axillary lymph node metastases.原发性乳腺癌及同步腋窝淋巴结转移灶的DNA指数与细胞周期分析
Breast Cancer Res Treat. 1989 Jan;13(1):17-22. doi: 10.1007/BF01806546.